Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer/GSK Levitra Study: Erectile Dysfunction Agent Works In As Few As 10 Minutes

This article was originally published in The Pink Sheet Daily

Executive Summary

Marketing efforts by competitors will result in "volatility" in quarterly sales figures for Levitra, Bayer says. The drug had sales of approximately $78 mil. for the quarter.

You may also be interested in...



“Cialis Challenge”: Initial Results Indicate Patients Prefer Lilly/Icos Agent

The joint venture is pleased with the early response to its sampling program; the “overwhelming majority” of 10,000 vouchers have been redeemed for Cialis, rather than for competing erectile dysfunction therapies Levitra and Viagra.

Pfizer Viagra "Value Card" Offers Buy-Six-Get-One-Free Script Deal

The card program is available to patients who either pay out of pocket for Viagra or receive partial third-party coverage. Pfizer will dedicate full print and radio ads to the Value Card and update current TV commercials.

Super Bowl Ads Pit Levitra Against Cialis; Viagra Stays On The Sidelines

Erectile dysfunction ads mark new milestone in short history of DTC advertising on TV. Metaphor and euphemisms dominate in Levitra and Cialis ads.

Related Content

Topics

UsernamePublicRestriction

Register

PS059360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel